FDA Adds Warning Label to RSV Vaccines Abrysvo and Arexvy
Postmarketing observation shows increased risk for Guillain-Barré syndrome for 42 days postvaccination
Long COVID Burden Has Decreased Over Time in Health Care Workers
Highest number of symptoms reported by health care workers with Wild-type variant
Early-Life Infection Burden Linked to Risk for Later Infections
Risk increased for later moderate-to-severe infections and systemic antibiotic treatments
Eight in 10 Infants Received RSV Protection in the 2023 to 2024 Season
Findings seen within a single health care system during the early period of availability
Extended Nirmatrelvir/Ritonavir Beneficial for Some With Long COVID
Meaningful reduction in symptoms seen for some taking an extended course outside of the context of an acute infection
First U.S. Death From Bird Flu Reported in Louisiana
DoxyPEP Tied to Decreases in Sexually Transmitted Infections
Substantial declines seen in chlamydia and syphilis incidence after initiation
Immunocompromised Have Heterogeneous Antibody Response to RSV Vaccines
Median four-week preF IgG fold rise was 4.21; 61 percent of participants achieved seroconversion
Pertussis Cases Surging in the United States
While vaccination is the best way to protect against whooping cough, vaccination rates in children have fallen
FDA: Listeria Concerns Prompt Broccoli Recall at Walmart Stores
The affected bags are past their 'best by' date but may still be in freezers; no illnesses have been reported
